November 2019 FDA Recall Drug by Preferred Pharmaceuticals, Inc
D-0531-2020 - Presence of foreign substance

This Class II drug recall was voluntarily initiated by Preferred Pharmaceuticals, Inc on November 21, 2019 for the product Drug. The FDA reported the reason for recall as presence of foreign substance. The product was distributed in CA, FL, IL and the recall is currently terminated.

Recall Number: D-0531-2020

Reason for Recall
Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Initiated
11-21-2019
Reported
12-04-2019
Quantity

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Preferred Pharmaceuticals, Inc
Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl.oz. 118 mL, Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA. Mfg: Taro Pharm.; Hawthorne, NY; NDC 68788-7268-01

Batch or Lot Expiration Information

Lot# : I1718U, Exp. 3/2020; K0818L, Exp. 9/2020; L2718E, Exp. 9/2020; A2219E, Exp. 9/2020; C1519S, Exp. 12/2020; C2819Y, Exp. 12/2020; E2019V, Exp. 11/2020